View Single Post
  #1  
Old 02-03-2006, 01:49 AM
spotty14 spotty14 is offline
Senior Member
 
Join Date: Dec 2004
Posts: 365
Default

On 2/1 Nastech Pharmaceutical Co granted the development rights to Proctor and Gamble to develop a once daily nasal spray of parathyrod hormone, currently called PTH1-34 - currently known as Forteo. This is in Stage 1 FDA trials and hopefully is effective as the injectable Forteo. I'm hoping that treatment with the spray will allow for long term treatment not limited to 18 months to 2 years only then being left with no effective treatment except oral biophosphates which irritate most patients stomachs. Looks like good news to me.
__________________
7/05 EMG/Nerve Conduction Tests
8/04 Disqualified from ADR clinical trial due to severe osteoporosis -- getting treatment
3/04 updated MRI
11/2000 IDET L 3/4, L4/5
1/2000 Discogram
numerous epidural injections
physical therapy
Reply With Quote